Media and Games Invest SE (M8G.DE) Corporate Presentation from NobleCon18News and Market Data on Media and Games Invest SENobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


4/14/2026
Manufacturing
Release – Preliminary Q1 2026 Net Sales Expected to Exceed Annual Guidance Run-rate
NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies with six sigma quality, today announced that its preliminary...
6 min read
‌


4/14/2026
Health
Release – GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancer, today highlighted the urgent challenges caused by the supply-constrained, global orthopoxvirus vaccine...
6 min read
‌


4/14/2026
Technology
Release – SKYX Signs Strategic Partnership Agreement with Prominent European Hotel & Real Estate Developer, Jean-François Ott, Founder of Group OTT, to Deploy Its Advanced and Smart Electrical Technologies as a Brand Standard Throughout Its Hotels and Buildings
SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced and smart home platform technology company with over 100 U.S. and global...
6 min read
‌


4/14/2026
Health
Release – Greenwich LifeSciences Provides Update on Financing Strategy
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent...
7 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.